The US President Donald Trump began his second term with a series of directives targeting the US National Institutes of ...

Massachusetts, USA-based start-up Magnet Biomedicine, which is advancing molecular glue discovery with rational selection and ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its ...

Medicare Part D spending for 10 selected diabetes drugs in the USA totaled $35.8 billion in 2023, an increase of 364% from ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) ...

Sino American biotech BeiGene has announced financial results and corporate updates from the fourth quarter and full year ...

Japanese biopharma Nxera Pharma has announced two deals in a single day with partners that will commercialize its products in ...

South Korean vaccine maker SK bioscience today revealed that it has received prior notification from the Pan American Health ...

Duality Biologics, a Chinese biotech specializing in antibody-drug conjugates (ADCs), has opted not to move forward at this ...

Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...

Kallyope’s latest obesity drug trial results show modest weight-loss effects that lag behind competing therapies in the ...

Encephalitis is a complex and often devastating condition that can leave lasting neurological damage in survivors. Despite ...